Nidan Laboratories and Healthcare Past Earnings Performance
Past criteria checks 3/6
Nidan Laboratories and Healthcare has been growing earnings at an average annual rate of 29.7%, while the Healthcare industry saw earnings growing at 29.7% annually. Revenues have been declining at an average rate of 19.2% per year. Nidan Laboratories and Healthcare's return on equity is 4.4%, and it has net margins of 14.3%.
Key information
29.7%
Earnings growth rate
24.5%
EPS growth rate
| Healthcare Industry Growth | 29.4% |
| Revenue growth rate | -19.2% |
| Return on equity | 4.4% |
| Net Margin | 14.3% |
| Last Earnings Update | 30 Sep 2023 |
Revenue & Expenses BreakdownBeta
How Nidan Laboratories and Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 220 | 31 | 53 | 0 |
| 30 Jun 23 | 231 | 33 | 52 | 0 |
| 31 Mar 23 | 243 | 35 | 52 | 0 |
| 31 Dec 22 | 257 | 34 | 48 | 0 |
| 30 Sep 22 | 272 | 32 | 43 | 0 |
| 30 Jun 22 | 289 | 27 | 39 | 0 |
| 31 Mar 22 | 297 | 27 | 39 | 0 |
| 31 Mar 21 | 208 | 23 | 28 | 0 |
| 31 Mar 20 | 222 | 7 | 42 | 0 |
| 31 Mar 19 | 206 | 2 | 40 | 0 |
Quality Earnings: NIDAN has high quality earnings.
Growing Profit Margin: NIDAN's current net profit margins (14.3%) are higher than last year (11.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NIDAN's earnings have grown significantly by 29.7% per year over the past 5 years.
Accelerating Growth: NIDAN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: NIDAN had negative earnings growth (-1.1%) over the past year, making it difficult to compare to the Healthcare industry average (28%).
Return on Equity
High ROE: NIDAN's Return on Equity (4.4%) is considered low.